Skip to main content
. 2018 Apr 27;15(6):9673–9680. doi: 10.3892/ol.2018.8592

Figure 5.

Figure 5.

Treatment with 6-O-angeloylplenolin reversed vincristine resistance in the HCT/VCR xenograft model. (A) The tumors were isolated and weighted after 12 days of treatment. **P<0.01 were compared with control group. (B) The tumor growth inhibition ratio was calculated (n=5). ||P<0.01 was compared with vincristine treatment alone. (C) The body weights of mice were monitored on the indicated day (n=5). VCR, vincristine.